Somatostatin, originally isolated from the hypothalamus as an inhibitor of growth hormone secretion [I], is released from somatostatin~ontaining D cells of the stomach [2] and pancreas [2,3] during the gastric phase of a meal [4]. In vivo, somatostatin is reported to inhibit the pepsinogen secretion induced by a meal [S] and the gastric acid secretion stimulated by histamine [6,7]. The presence of specific receptors for somatostatin on isolated gastric cells from the rat fundus [8] strongly suggests that somatostatin exerts a direct effect on these exocrine secretory processes: We have shown that secretin which stimulates pepsinogen [9] and mucous [lo] secretions is highly potent in stimulating cyclic AMP production in gastric glands isolated from the rat fundus and antrum, while histamine is only effective on the acid-secreting fundic preparation [ 1 l]. Here we have examined therefore the ability of somatostat~ to inhibit both secretin and histamine-induced cyclic AMP formation in our system. The effect of cimetidine, a specific Hz-receptor antagonist [ 121 was also investigated since it has been shown that histamine stimulates gastric acid secretion by interacting with an Hz-receptor cyclic AMP system [ 131 present in parietal cells ]14]. Our data demonstrate that somatostatin (1 O-‘low6 M) reduces considerably the effect of histamine on the cyclic AMP production in a non-competitive way, while cimetidine (1 O-*-l O4 M) inhibits competitively the histamine stimulation. In contrast, no effect of somatostatin was found on the cyclic AMP
Read full abstract